More on ImmunoCellular Q2 results

|About: ImmunoCellular Therape... (IMUC)|By:, SA News Editor

ImmunoCellular Therapeutics (IMUC -2.6%) Q2 results: Revenues: $0; Operating Loss: ($2.4M) (-11.2%); Net Loss: ($2.2M) (-999%); Loss Per Share: ($0.04); Quick Assets: $25.7M (-6.9%).

No guidance given.